Developer docs
API playgroundTry for free, no card

Search company profiles

ImVitro

Full company profile

uuid0002hw7

Namestring
ImVitro
Legal namestring
ImVitro
Websiteurl
im-vitro.com
Company typeenum
Private
Founded yearint
2019
Short descriptiontext

ImVitro is a Paris-based SaaS/medical-software company founded in 2019 that builds AI-driven computer-vision software to analyze IVF fertility imaging for fertility clinics and clinicians. It sells via subscription/licensing through direct enterprise sales and is pursuing U.S. expansion.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
IVF imaging software, fertility clinic AI, embryo assessment, computer vision healthcare, AI fertility analysis
Industry3 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAK
Women’s Health & Fertility Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare AI Software / IVF Imaging Software
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software licensing/subscription
TypeSubscription Recurring
Description

AI-driven software sold or licensed to IVF fertility clinics as a tool to assist clinicians in fertility treatments. Revenue likely derives from software subscriptions or licensing fees to healthcare providers.

finsmes.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

ImVitro develops and sells an AI-driven SaaS software platform that applies computer vision to in vitro fertilization (IVF) imaging. The software analyzes fertility images to assist fertility clinics and clinicians in IVF treatment workflows, with the goal of improving clinical decision-making and treatment outcomes.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1AI-Driven IVF Fertility Imaging Software
CategoryHealthcare AI Software / IVF Imaging Software
Description

AI-powered software that applies computer vision to IVF fertility imaging to assist fertility clinics and clinicians in analyzing fertility images, supporting clinical decisions in IVF treatments such as embryo assessment and follicle counting.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Peers10 records
TypeDirect peer
Description

AIVF is an Israel- and U.S.-based company applying AI to IVF clinic workflows including embryo assessment and cycle optimization. It directly competes with ImVitro in AI software for fertility clinics, targeting the same customer base and use cases.

TypeDirect peer
Description

Alife Health builds an AI platform for IVF clinics that supports embryo ranking, cycle decisions, and clinical workflow analytics. It is one of the most direct comparables to ImVitro in AI-driven IVF clinical-decision software.

TypeDirect peer
Description

Future Fertility provides AI-powered oocyte and egg quality assessment for fertility clinics. It overlaps directly with ImVitro's imaging-based AI approach in the IVF patient journey and serves the same clinician customer.

4Embryonics
TypeDirect peer
Description

Embryonics applies AI/computer vision to embryo selection in IVF. As a venture-backed startup in the same niche, it competes with ImVitro for clinic partnerships in AI embryo assessment.

5Presagen
TypeEmerging player
Description

Presagen develops AI for women's health and fertility imaging, including embryo and IVF-related applications. It overlaps with ImVitro in AI women's-health imaging but operates a broader platform across multiple fertility use cases.

TypeBroad incumbent
Description

Vitrolife is an established global provider of IVF media, consumables, and lab solutions. As an incumbent in the IVF clinic stack, it is a comparable channel partner and a potential integrator or competitor for AI-driven IVF imaging software.

TypeBroad incumbent
Description

Genea Biomedx develops connected IVF lab devices and software platforms. Its emphasis on digitizing IVF lab workflows makes it an incumbent peer comparable to ImVitro's clinic-side software positioning.

TypeBroad incumbent
Description

CooperSurgical is a large women's-health and fertility medical device company offering a wide portfolio of IVF products and services. It represents the broader incumbent space in which ImVitro's clinic-software offering competes for budget and integration.

TypeEmerging player
Description

TMRW Life Sciences provides automated cryostorage and digital specimen management for IVF clinics. While focused on storage rather than imaging, it is part of the same emerging digital-software stack modernizing IVF labs.

TypeBroad incumbent
Description

Ferring Pharmaceuticals is a global reproductive medicine company active in IVF therapeutics and fertility clinics. As a broad incumbent in the fertility ecosystem, it represents an important industry context and potential strategic partner for AI IVF software players like ImVitro.

Market position
Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ImVitro

Healthcare AI Software / IVF Imaging Softwareim-vitro.com

ImVitro is a Paris-based SaaS/medical-software company founded in 2019 that builds AI-driven computer-vision software to analyze IVF fertility imaging for fertility clinics and clinicians. It sells via subscription/licensing through direct enterprise sales and is pursuing U.S. expansion.

ImVitro firmographics

Firmographics
Name
ImVitro
Legal name
ImVitro
Website
https://im-vitro.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
ImVitro is a Paris-based SaaS/medical-software company founded in 2019 that builds AI-driven computer-vision software to analyze IVF fertility imaging for fertility clinics and clinicians. It sells via subscription/licensing through direct enterprise sales and is pursuing U.S. expansion.
Ownership category
akta.pro rank

ImVitro industry classification

Industry
Product category
Healthcare AI Software / IVF Imaging Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAK
Women’s Health & Fertility Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • IVF imaging software
  • Fertility clinic AI
  • Embryo assessment
  • Computer vision healthcare
  • AI fertility analysis

Where ImVitro is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

ImVitro business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Software licensing/subscription: AI-driven software sold or licensed to IVF fertility clinics as a tool to assist clinicians in fertility treatments. Revenue likely derives from software subscriptions or licensing fees to healthcare providers.

Go-to-market motion1 record

Distribution channels1 record

ImVitro product offering

Product offering

Core offering

ImVitro develops and sells an AI-driven SaaS software platform that applies computer vision to in vitro fertilization (IVF) imaging. The software analyzes fertility images to assist fertility clinics and clinicians in IVF treatment workflows, with the goal of improving clinical decision-making and treatment outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI-Driven IVF Fertility Imaging Software AI-powered software that applies computer vision to IVF fertility imaging to assist fertility clinics and clinicians in analyzing fertility images, supporting clinical decisions in IVF treatments such as embryo assessment and follicle counting.

Companies that use ImVitro

Customer profile

Segments1 record

Ideal customer profiles1 record

ImVitro technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

ImVitro partnerships and signals

Strategic signal

Scale indicators1 record

ImVitro competitors and assessment

Company assessment

Direct peers

  • AIVF: AIVF is an Israel- and U.S.-based company applying AI to IVF clinic workflows including embryo assessment and cycle optimization. It directly competes with ImVitro in AI software for fertility clinics, targeting the same customer base and use cases.
  • Alife Health: Alife Health builds an AI platform for IVF clinics that supports embryo ranking, cycle decisions, and clinical workflow analytics. It is one of the most direct comparables to ImVitro in AI-driven IVF clinical-decision software.
  • Future Fertility: Future Fertility provides AI-powered oocyte and egg quality assessment for fertility clinics. It overlaps directly with ImVitro's imaging-based AI approach in the IVF patient journey and serves the same clinician customer.
  • Embryonics: Embryonics applies AI/computer vision to embryo selection in IVF. As a venture-backed startup in the same niche, it competes with ImVitro for clinic partnerships in AI embryo assessment.

Emerging players

  • Presagen: Presagen develops AI for women's health and fertility imaging, including embryo and IVF-related applications. It overlaps with ImVitro in AI women's-health imaging but operates a broader platform across multiple fertility use cases.
  • TMRW Life Sciences: TMRW Life Sciences provides automated cryostorage and digital specimen management for IVF clinics. While focused on storage rather than imaging, it is part of the same emerging digital-software stack modernizing IVF labs.

Broad incumbents

  • Vitrolife: Vitrolife is an established global provider of IVF media, consumables, and lab solutions. As an incumbent in the IVF clinic stack, it is a comparable channel partner and a potential integrator or competitor for AI-driven IVF imaging software.
  • Genea Biomedx: Genea Biomedx develops connected IVF lab devices and software platforms. Its emphasis on digitizing IVF lab workflows makes it an incumbent peer comparable to ImVitro's clinic-side software positioning.
  • CooperSurgical: CooperSurgical is a large women's-health and fertility medical device company offering a wide portfolio of IVF products and services. It represents the broader incumbent space in which ImVitro's clinic-software offering competes for budget and integration.
  • Ferring Pharmaceuticals: Ferring Pharmaceuticals is a global reproductive medicine company active in IVF therapeutics and fertility clinics. As a broad incumbent in the fertility ecosystem, it represents an important industry context and potential strategic partner for AI IVF software players like ImVitro.

Market position

Customer concentration

ImVitro financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ImVitro leadership team

Management profile

Number of profiles

Profiles2 records

ImVitro funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ImVitro M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ImVitro

What does ImVitro do?

ImVitro develops and sells an AI-driven SaaS software platform that applies computer vision to in vitro fertilization (IVF) imaging. The software analyzes fertility images to assist fertility clinics and clinicians in IVF treatment workflows, with the goal of improving clinical decision-making and treatment outcomes.

Is ImVitro a public or private company?

ImVitro is a private company. It is classified as venture growth investor backed and is currently operating.

When was ImVitro founded?

ImVitro was founded in 2019. It employs 1 to 10 people.

Where is ImVitro based?

ImVitro is headquartered in Paris, France, in the Europe region.

How does ImVitro make money?

One revenue line is on record: software licensing/subscription.

Who are ImVitro's main competitors?

Direct peers on record are AIVF, Alife Health, Future Fertility and Embryonics. Emerging players are Presagen and TMRW Life Sciences. Broad incumbents are Vitrolife, Genea Biomedx, CooperSurgical and Ferring Pharmaceuticals.

Does ImVitro have an API?

No public API is recorded for ImVitro.

What industry is ImVitro in?

ImVitro's product category is Healthcare AI Software / IVF Imaging Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals